Here are four notes:
1. The initiative evaluate the effects of obeticholic acid and other product candidates on the microbiome in a number of chronic liver diseases, beginning with nonalcoholic steatohepatitis.
2. University of Pennsylvania’s PennCHOP Microbiome Program is a collaboration between the Perelman School of Medicine at the University of Pennsylvania in Philadelphia and the Children’s Hospital of Philadelphia.
3. PennCHOP will analyze samples from Intercept’s ongoing international Phase 3 REGENERATE trial in NASH patients with fibrosis and evaluate how OCA influences the composition and activity of the resident microbiota in the gastrointestinal tract.
4. Financial details of the seven-year collaboration will not be disclosed.
More articles on GI/endoscopy:
3 points on the 2016 Gut Microbiota for Health World Summit
Central Illinois Endoscopy Center performs free colonoscopy for veterans
5 key thoughts from Dr. Brian Hudes on GI physician entrepreneurship
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
